These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Correlation between insulin resistance and intracranial atherosclerosis in patients with ischemic stroke without diabetes. Park HY; Kyeong-Ho ; Park DS; Lee HS; Chang H; Kim YS; Cho KH J Stroke Cerebrovasc Dis; 2008; 17(6):401-5. PubMed ID: 18984435 [TBL] [Abstract][Full Text] [Related]
3. Lipid management reduces cardiovascular complications in individuals with diabetes and prediabetes. Gosavi A; Flaker G; Gardner D Prev Cardiol; 2006; 9(2):102-7; quiz 108-9. PubMed ID: 16603829 [TBL] [Abstract][Full Text] [Related]
4. Role of oxidative stress in development of cardiovascular complications in diabetes mellitus. Haidara MA; Yassin HZ; Rateb M; Ammar H; Zorkani MA Curr Vasc Pharmacol; 2006 Jul; 4(3):215-27. PubMed ID: 16842139 [TBL] [Abstract][Full Text] [Related]
5. Metabolic syndrome and intracranial atherosclerosis: a new link? Bushnell CD; Guzick D Neurology; 2005 Jul; 65(2):188-9. PubMed ID: 16043783 [No Abstract] [Full Text] [Related]
9. From hyperglycemia to the risk of cardiovascular disease. Leiter LA Rev Cardiovasc Med; 2006; 7 Suppl 2():S3-9. PubMed ID: 17224875 [TBL] [Abstract][Full Text] [Related]
10. Diabetes and stroke: part one--risk factors and pathophysiology. Baliga BS; Weinberger J Curr Cardiol Rep; 2006 Feb; 8(1):23-8. PubMed ID: 16507231 [TBL] [Abstract][Full Text] [Related]
11. Reduction of cardiovascular morbidity and mortality in type 2 diabetes. A rational approach to hypoglycemic therapy. Spallarossa P; Barsotti A; Cordera R; Ghigliotti G; Maggi D; Brunelli C J Endocrinol Invest; 2004 May; 27(5):485-95. PubMed ID: 15279085 [TBL] [Abstract][Full Text] [Related]
12. [Insulin in the treatment of ischemic stroke]. Samson Y; Bruandet M; Lejeune M; Deltour S; Grimaldi A Presse Med; 2006 Apr; 35(4 Pt 2):696-8. PubMed ID: 16614616 [TBL] [Abstract][Full Text] [Related]
13. Metabolic syndrome clusters and the risk of incident stroke: the atherosclerosis risk in communities (ARIC) study. Rodriguez-Colon SM; Mo J; Duan Y; Liu J; Caulfield JE; Jin X; Liao D Stroke; 2009 Jan; 40(1):200-5. PubMed ID: 18927451 [TBL] [Abstract][Full Text] [Related]
14. Improved outcome with aggressive treatment of hyperglycemia: hype or hope? Diringer MN Neurology; 2005 Apr; 64(8):1330-1. PubMed ID: 15851717 [No Abstract] [Full Text] [Related]
15. Diabetes and stroke: part two--treating diabetes and stress hyperglycemia in hospitalized stroke patients. Burroughs V; Weinberger J Curr Cardiol Rep; 2006 Feb; 8(1):29-32. PubMed ID: 16507232 [TBL] [Abstract][Full Text] [Related]
16. Incretin therapy for type 2 diabetes mellitus. Klonoff DC Adv Ther; 2010 Dec; 27(12):881-94. PubMed ID: 20978879 [TBL] [Abstract][Full Text] [Related]
18. Intensive vs Standard Treatment of Hyperglycemia and Functional Outcome in Patients With Acute Ischemic Stroke: The SHINE Randomized Clinical Trial. Johnston KC; Bruno A; Pauls Q; Hall CE; Barrett KM; Barsan W; Fansler A; Van de Bruinhorst K; Janis S; Durkalski-Mauldin VL; JAMA; 2019 Jul; 322(4):326-335. PubMed ID: 31334795 [TBL] [Abstract][Full Text] [Related]
19. Treating hyperglycemia and diabetes with insulin therapy: transition from inpatient to outpatient care. Lavernia F Medscape J Med; 2008; 10(9):216; quiz 216. PubMed ID: 19008977 [TBL] [Abstract][Full Text] [Related]